Immunopharmacology and Inflammation, Softcover reprint of the original 1st ed. 2018

Carlo Riccardi is full professor of Pharmacology at the Perugia University Medical School, Italy, and currently the Director of the Department of Medicine. Prof. Riccardi completed both his Pharmacy and Medical degrees at the University of Perugia, and a period as a Research Associate, at the Department of Pathology, State University of New York at Buffalo. He was also Guest Visitor in the Laboratory of Immunodiagnosis, N.C.I., N.I.H., in Bethesda, Maryland. His field of research is the immunopharmacology, with a particular focus on the molecular mechanisms of action of glucocorticoids in inflammation and the mechanisms regulating the lymphocyte activation, growth and differentiation. These studies have been the subject of more than 270 publications in international journals. He participated to numerous congresses and meetings worldwide as invited speaker and/or chairman for his competences in Pharmacology, Inflammation and Immunology, Glucocorticoids, Apoptosis, Cell Growth Regulation, GILZ and GITR. He is member of the Editorial Board and referee of many international scientific Journals. He is also member of many scientific societies, such as International Association of Inflammation Societies, IUPHAR, and Italian Society of Pharmacology, of which he has been President. Throughout his career, he has obtained several grants to develop and work in the research field of pharmacology.

Francesca Levi-Schaffer is a Professor at The Hebrew University of Jerusalem Institute for Drug Research, School of Pharmacy, Faculty of Medicine. She holds the Isaac and Myrna Kaye Chair in Immunopharmacology. Prof. Levi-Schaffer was born in Italy and completed her PharmD degree at the University of Milano, her PhD degree in Immunology at the Weizmann Institute, Israel, and her post-doctorate at Harvard Medical School. Prof. Levi-Schaffer has published 160 articles in peer-reviewed journals, 83 reviews and editorials and 25 book chapters. She has two p

Includes atherosclerosis, ischemic-reperfusion injury, sepsis/multiply organ failure and COPD

Discusses current trends in inflammatory mediator and anti-inflammatory drug research

Presents an array of therapeutic approaches towards both inflammatory and autoimmune diseases